5 Varicella Anaphylaxis Limited Strong Convincingly Supports
6 Influenza Anaphylaxis Limited Strong Convincingly Supports
8 Hepatitis B Anaphylaxis Insufficient Strong (in yeast-sensitive individuals) Convincingly Supports (in yeast-sensitive individuals)
10 TT containing Anaphylaxis Insufficient Strong Convincingly Supports
11 Meningococcal Anaphylaxis Insufficient Strong Convincingly Supports
12 Injection- Related Event Deltoid Bursitis Limited Strong Convincingly Supports
12 Injection- Related Event Syncope Insufficient Strong Convincingly Supports
4 MMR Febrile Seizures High (increase) Intermediate Convincingly Supports
9 HPV Anaphylaxis Insufficient Intermediate Favors Acceptanceb
4 MMR Transient Arthralgia Moderate (increase)
(rubella)
Insufficient (measles or mumps)
Intermediate (rubella) Lacking (measles or mumps) Favors Acceptancec
6 Influenza Oculorespiratory Syndrome Moderate (increase) Intermediate Favors Acceptance'
8 Hepatitis B Acute Disseminated Encephalomyelitis Low-Intermediate Inadequate
8 Hepatitis B First Dcmyclinating Event in Adults Low-Intermediate Inadequate
8 Hepatitis B Onset or Exacerbation of Vasculitis Insufficient Low-Intermediate Inadequate


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement